https://www.marketscreener.com/quote/stock/CORCEPT-THERAPEUTICS-INCO-40449488/news/Corcept-Completes-Enrollment-in-Phase-2-Dazals-Trial-in-Patients-with-Amyotrophic-Lateral-Sclerosis-46437990/?utm_source=telegram&utm_medium=social&utm_campaign=share